InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Yarema Kristin, Directeur Commercial. Insider active across 2 companies, notably Atara Biotherapeutics, Inc.. In total, 5 disclosures have been logged. Total volume traded: €66k. The latest transaction was filed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
045,533 shares0
Common Stock
SEC:0001140361-22-007766:0·
€24,0742,021 shares@ €11.9120.018% mcap100.0% of flow
Common Stock
SEC:0001567619-21-012110·
Ideal exit: 8 Mar 2022 (T+270)
€24,0742,021 shares@ €11.9120.030% mcap57.1% of flow
Common Stock
SEC:0001567619-21-012110:0·
Ideal exit: 8 Mar 2022 (T+270)
€9,058761 shares@ €11.9028100.0% of flow
Common Stock
SEC:0001209191-21-034422·
€9,058761 shares@ €11.90280.011% mcap21.5% of flow
Common Stock
SEC:0001209191-21-034422:0·
5 of 5 declarations
About Yarema Kristin
Kristin Yarema is the Chief Commercial Officer at Atara Biotherapeutics, Inc. She is responsible for the commercial strategy and direction of the company's activities. Her role is crucial in developing initiatives aimed at increasing market share and strengthening the company's position in the biopharmaceutical sector. She brings her expertise in management and commercial strategy.
